Humanigen Inc (HGENQ)

[cowtown jay]

I know management reads the message boards. That's how I asked them to contact their House and Senate colleagues.

And I still think what I said before, that the 10-Q is only awaiting an update. We've seen several SEC filings from Baudax, in what could be in preparation for a merger with us. But the delay could also be related to developing news about a cure for CMML and aGvHD.

IMPACT is going to do an interim assessment of the first 20 patients who get enrolled in their 18 treatment centers.

"The first stage of the trial is expected to treat 20 participants with lenzilumab before conducting an interim assessment of safety, efficacy, and feasibility."

https://ir.humanigen.com/English/news/news-details/2023/Humanigen-Announces-First-Participant-Dosed-in-RATinG-Trial-of-Lenzilumab-for-Early-Treatment-of-Acute-Graft-Versus-Host-Disease-Following-Allogeneic-Stem-Cell-Transplantation/default.aspx

So it may not take long for the data monitoring committee to collect and review data from 20 patients, from 18 sites, and making a recommendation to a second trial stage. Maybe we'll hear something about that CMML patient who progressed to needing aGvHD to be cured of his cancer.

As I noted before regarding CMML, "Humanigen and the Principal Investigator are assessing regulatory pathways that may enable
early results to support a regulatory submission and potential approval by the Therapeutic Goods Administration in
Australia, which could be expanded through Project Orbis10 to the United States and the United Kingdom."

https://s28.q4cdn.com/539885110/files/doc_news/Humanigen-Presents-Promising-New-Hematologic-Data-from-PREACH-M-Trial-for-Chronic-Myelomonocytic-Leukemia-Treatment-at-the-2023-Europ-OYZCQ.pdf

These are both major developments. If the timing just worked out that the RATinG study findings for aGvHD can be accumulated while PREACH-M results for CMML are proposed for regulatory approval in Australia, more power, MUCH more power, to us.

That will drive insane demand for our shares, at the same time that the company recalls their loaned shares. Personally, I just want and need to see the short squeeze initiated as soon as possible.